<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36098945</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7284</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of epidemiology</Title><ISOAbbreviation>Eur J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Spatio-temporal clustering of amyotrophic lateral sclerosis in France: A population-based study.</ArticleTitle><Pagination><StartPage>1181</StartPage><EndPage>1193</EndPage><MedlinePgn>1181-1193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10654-022-00904-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess spatial aggregates of amyotrophic lateral sclerosis (ALS) incident cases, using a solid geo-epidemiological statistical method, in France.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This population-based study (2003-2011) investigated 47.1 million person-years of follow-up (PYFU). Case ascertainment of incident ALS cases was based on multiple sources (ALS referral centers, hospital centres and health insurance data). Neurologists confirmed all ALS diagnoses. Exhaustiveness was estimated through capture-recapture. Aggregates were investigated in four steps: (a) geographical modelling (standardized incidence ratio (SIR) calculation), (b) analysis of the spatial distribution of incidence (Phothoff-Winttinghill's test, Global Moran's Index, Kulldorf's spatial scan statistic, Local Moran's Index), (c) classification of the level of certainty of spatial aggregates (i.e. definite cluster; probable over-incidence area; possible over-incidence area) and (d) evaluation of the robustness of the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The standardized incidence of ALS was 2.46/100,000 PYFU (95% CI 2.31-2.63, European population as reference) based on 1199 incident cases. We identified 13 areas of spatial aggregates: one cluster (stable in robustness analysis), five probable over-incidence areas (2 stable in robustness analysis) and seven possible over-incidence areas (including 4 stable areas in robustness analysis). A cluster was identified in the Rh&#xf4;ne-Alpes region: 100 observed vs 54.07 expected cases for 2,411,514 PYFU, SIR: 1.85 (95% CI 1.50-2.25).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We report here one of the largest investigations of incidence and spatial aggregation of ALS ever performed in a western country. Using a solid methodology framework for case ascertainment and cluster analysis, we identified 13 areas that warrant further investigation.</AbstractText><CopyrightInformation>&#xa9; 2022. Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Boum&#xe9;diene</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Inserm U1094, IRD U270, USC1501 INRAE, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Marin</LastName><ForeName>Beno&#xee;t</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Inserm U1094, IRD U270, USC1501 INRAE, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5990-7534</Identifier><AffiliationInfo><Affiliation>Inserm U1094, IRD U270, USC1501 INRAE, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Centre de Reference SLA et Autres Maladies du Neurone Moteur, CHU Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonneterre</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, CNRS, Grenoble INP, TIMC, 38000, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camu</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Explorations Neurologiques et Centre SLA, CHU et Universit&#xe9; de Montpellier, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagrange</LastName><ForeName>Emmeline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, CHU Grenoble-Alpes (Grenoble Teaching Hospital), Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besson</LastName><ForeName>G&#xe9;rard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, CHU Grenoble-Alpes (Grenoble Teaching Hospital), Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esselin</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Explorations Neurologiques et Centre SLA, CHU et Universit&#xe9; de Montpellier, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De La Cruz</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Explorations Neurologiques et Centre SLA, CHU et Universit&#xe9; de Montpellier, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lautrette</LastName><ForeName>G&#xe9;raldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Centre de Reference SLA et Autres Maladies du Neurone Moteur, CHU Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preux</LastName><ForeName>Pierre Marie</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Inserm U1094, IRD U270, USC1501 INRAE, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CEBIMER, Centre d'Epid&#xe9;miologie, de Biostatistique et de M&#xe9;thodologie de la Recherche, CHU Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Inserm U1094, IRD U270, USC1501 INRAE, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France. philippe.couratier@unilim.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Centre de Reference SLA et Autres Maladies du Neurone Moteur, CHU Limoges, Limoges, France. philippe.couratier@unilim.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>BMAALS group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ANR-11-CESA-0014</GrantID><Agency>Agence Nationale de la Recherche</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Epidemiol</MedlineTA><NlmUniqueID>8508062</NlmUniqueID><ISSNLinking>0393-2990</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cluster analysis</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">France</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Registries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36098945</ArticleId><ArticleId IdType="doi">10.1007/s10654-022-00904-2</ArticleId><ArticleId IdType="pii">10.1007/s10654-022-00904-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marin B, Boum&#xe9;diene F, Logroscino G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57&#x2013;74. https://doi.org/10.1093/ije/dyw061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Logroscino G, Boum&#xe9;diene F, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229&#x2013;45. https://doi.org/10.1007/s10654-015-0090-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0090-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. https://doi.org/10.1038/nn.3584 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V, Pansarasa O, Diamanti L, et al. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016;31:7&#x2013;19.</Citation></Reference><Reference><Citation>Filippini T, Tesauro M, Fiore M, et al. Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case-control study. Int J Environ Res Pub Health. 2020. https://doi.org/10.3390/ijerph17082882 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082882</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquez GM, Waller LA, Grimson R, Wartenberg D. The analysis of disease clusters, Part I: state of the art. Infect Control Hosp Epidemiol. 1996;17:319&#x2013;27. https://doi.org/10.1086/647301 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/647301</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Pupillo E, Belometti C, et al. Geographical clusters of amyotrophic lateral sclerosis and the bradford hill criteria. Amyotroph Later Scler Front Degener. 2021;23(5&#x2013;6):329&#x2013;43.</Citation></Reference><Reference><Citation>Olsen SF, Martuzzi M, Elliott P. Cluster analysis and disease mapping&#x2013;why, when, and how? a step by step guide. BMJ. 1996;313:863&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.313.7061.863</ArticleId></ArticleIdList></Reference><Reference><Citation>Plato CC, Garruto RM, Galasko D, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003;157:149&#x2013;57. https://doi.org/10.1093/aje/kwf175 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwf175</ArticleId></ArticleIdList></Reference><Reference><Citation>Murch SJ, Cox PA, Banack SA, et al. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from guam. Acta Neurol Scand. 2004;110:267&#x2013;9. https://doi.org/10.1111/j.1600-0404.2004.00320.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2004.00320.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki S, Iwahashi Y, Kuroiwa Y. Epidemiological study of amyotrophic lateral sclerosis and allied disorders in the kii peninsula (Japan). J Neurol Sci. 1967;4:279&#x2013;87. https://doi.org/10.1016/0022-510x(67)90106-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(67)90106-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kihira T, Yoshida S, Kondo T, et al. An increase in ALS incidence on the Kii Peninsula, 1960&#x2013;2009: a possible link to change in drinking water source. Amyotroph Later Scler. 2012;13:347&#x2013;50. https://doi.org/10.3109/17482968.2012.674140 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.674140</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliaretti G, Berchialla P, Dalmasso P, et al. Amyotrophic lateral sclerosis in piedmont (Italy): a Bayesian spatial analysis of the incident cases. Amyotroph Later Scler Front Degener. 2013;14:58&#x2013;65. https://doi.org/10.3109/21678421.2012.733401 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.733401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lannuzel A, Mecharles S, Tressi&#xe8;res B, et al. Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the caribbean island of guadeloupe: a new focus of ALS associated with parkinsonism. Amyotroph Later Scler Front Degener. 2015;16:216&#x2013;23. https://doi.org/10.3109/21678421.2014.992026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.992026</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedetti S, Lucchini G, Del B&#xf2; C, et al. Blood trace metals in a sporadic amyotrophic lateral sclerosis geographical cluster. Biometals Int J Role Met Ions Biol Biochem Med. 2017;30:355&#x2013;65. https://doi.org/10.1007/s10534-017-0011-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-017-0011-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilness AW, Hichberg FH. Amyotrophic lateral sclerosis in a high selenium environment. JAMA. 1977;237:2843&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1977.03270530051023</ArticleId></ArticleIdList></Reference><Reference><Citation>Masseret E, Banack S, Boum&#xe9;di&#xe8;ne F, et al. Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France. PLoS ONE. 2013;8: e83406. https://doi.org/10.1371/journal.pone.0083406 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083406</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Metcalf JS, Bradley WG, Cox PA. Detection of cyanobacterial neurotoxin &#x3b2;-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida. Toxicon Off J Int Soc Toxinol. 2014;90:167&#x2013;73. https://doi.org/10.1016/j.toxicon.2014.07.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2014.07.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Delzor A, Couratier P, Boum&#xe9;di&#xe8;ne F, et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open. 2014;4: e005528. https://doi.org/10.1136/bmjopen-2014-005528 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005528</ArticleId></ArticleIdList></Reference><Reference><Citation>Delzor A, Marin B, Boumediene F, et al. BMAALS: a French national project searching for a link between amyotrophic lateral sclerosis and the neurotoxic amino acid L-BMAA. Amyotroph Later Scler Front Degener. 2014;15:155&#x2013;6. https://doi.org/10.3109/21678421.2013.837933 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.837933</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Hamidou B, Couratier P, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe&#x2013;the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21(1292&#x2013;1300):e78-79. https://doi.org/10.1111/ene.12474 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12474</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Later Scler Mot Neuron Disord. 2000;1:293&#x2013;9. https://doi.org/10.1080/146608200300079536 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995;17:243&#x2013;64. https://doi.org/10.1093/oxfordjournals.epirev.a036192 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.epirev.a036192</ArticleId></ArticleIdList></Reference><Reference><Citation>Orton H, Rickard R, Gabella B. Capture-recapture estimation using statistical software. Epidemiol Camb Mass. 1999;10:563&#x2013;4. https://doi.org/10.1097/00001648-199909000-00021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-199909000-00021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto Y, Ishiguro M, Kitagawa G. Akaike Information Criterion Statistics. Netherlands: Springer; 1986.</Citation></Reference><Reference><Citation>Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6:461&#x2013;4. https://doi.org/10.1214/aos/1176344136 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aos/1176344136</ArticleId></ArticleIdList></Reference><Reference><Citation>Germonneau P, Thillaut H, Santo GDE, E, Borraz O,. Aspects m&#xe9;thodologiques de l&#x2019;investigation des signalements d&#x2019;agr&#xe9;gats spatio-temporels de maladies non infectieuses. Environ Risques Sant&#xe9;. 2005;4:329&#x2013;34.</Citation></Reference><Reference><Citation>Breslow NE, Day NE (1987) Statistical methods in cancer research. volume II--the design and analysis of cohort studies. IARC Sci Publ: 1&#x2013;406</Citation></Reference><Reference><Citation>Potthoff RF (2014) Homogeneity, Potthoff-Whittinghill Tests of. In: Wiley StatsRef: Stat Refer Online American Cancer Soc</Citation></Reference><Reference><Citation>Anselin L. Local Indicators of spatial association&#x2014;ISA. Geogr Anal. 2010;27:93&#x2013;115. https://doi.org/10.1111/j.1538-4632.1995.tb00338.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-4632.1995.tb00338.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med. 1995;14:799&#x2013;810. https://doi.org/10.1002/sim.4780140809 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780140809</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum A, Biraben J-N. Cliff A.D. et Ord J.K. &#x2014; spatial processes. Mode appl Popul. 1982;37:963&#x2013;963.</Citation></Reference><Reference><Citation>Lagrange E, Bonneterre V, Talbot K, et al (2017) A high-incidence cluster of ALS in the French Alps: common environment and multiple exposures. In: RISE 2nd International Meeting on Environmental Health 2017, Strasbourg, France.</Citation></Reference><Reference><Citation>Lagrange E, Vernoux JP, Reis J, et al. An amyotrophic lateral sclerosis hot spot in the French alps associated with genotoxic fungi. J Neurol Sci. 2021;427: 117558. https://doi.org/10.1016/j.jns.2021.117558 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagrange E, Juntas-Morales R, Pageot N, et al. The cyanotoxin BMAA and increased incidence in ALS clusters: a public health concern in France. Amyotroph Later Scler Front Degener. 2018;19:180.</Citation></Reference><Reference><Citation>Nicoletti A, Vasta R, Venti V, et al. The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals. Eur J Neurol. 2016;23:964&#x2013;72. https://doi.org/10.1111/ene.12973 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12973</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumediene F, Vasta R, Rascun&#xe0; C, et al. Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy. Eur J Neurol. 2019;26:e90&#x2013;1. https://doi.org/10.1111/ene.14011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14011</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna J, Leleu J-P, Preux P-M, et al. Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based study. Environ Res. 2019;176: 108525. https://doi.org/10.1016/j.envres.2019.108525 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2019.108525</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385&#x2013;90. https://doi.org/10.1136/jnnp.2009.183525 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52:93&#x2013;103. https://doi.org/10.1159/000493386 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493386</ArticleId></ArticleIdList></Reference><Reference><Citation>Erazo D, Luna J, Preux P-M, et al. Amyotrophic lateral sclerosis mortality rates in latin America and the caribbean: a meta-analysis. Amyotroph Later Scler Front Degener. 2022. https://doi.org/10.1080/21678421.2022.2048310 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2022.2048310</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M, Marin B, et al. Global, regional, and national burden of motor neuron diseases 1990&#x2013;2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17:1083&#x2013;97. https://doi.org/10.1016/S1474-4422(18)30404-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30404-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Vajda A, Heverin M, et al. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology. 2015;84:1537&#x2013;44. https://doi.org/10.1212/WNL.0000000000001477 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001477</ArticleId></ArticleIdList></Reference><Reference><Citation>Uenal H, Rosenbohm A, Kufeldt J, et al. Incidence and geographical variation of amyotrophic lateral sclerosis (als) in southern germany &#x2013; completeness of the ALS registry Swabia. PLoS ONE. 2014;9: e93932. https://doi.org/10.1371/journal.pone.0093932 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093932</ArticleId></ArticleIdList></Reference><Reference><Citation>Caller TA, Chipman JW, Field NC, Stommel EW. Spatial analysis of amyotrophic lateral sclerosis in northern new England, USA, 1997&#x2013;2009. Muscle Nerve. 2013;48:235&#x2013;41. https://doi.org/10.1002/mus.23761 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23761</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbick N, Hession S, Stommel E, Caller T. Mapping amyotrophic lateral sclerosis lake risk factors across northern New England. Int J Health Geogr. 2014;13:1. https://doi.org/10.1186/1476-072X-13-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-072X-13-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry KA, Fagliano J, Jordan HM, et al. Geographic variation of amyotrophic lateral sclerosis incidence in new Jersey, 2009&#x2013;2011. Am J Epidemiol. 2015;182:512&#x2013;9. https://doi.org/10.1093/aje/kwv095 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv095</ArticleId></ArticleIdList></Reference><Reference><Citation>Boum&#xe9;di&#xe8;ne F, Druet-Cabanac M, Marin B, et al. Contribution of geolocalisation to neuroepidemiological studies: incidence of ALS and environmental factors in limousin, France. J Neurol Sci. 2011;309:115&#x2013;22. https://doi.org/10.1016/j.jns.2011.07.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso V, Villaverde-Hueso A, Hens MJ, et al. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990&#x2013;2005). Amyotroph Later Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2011;12:192&#x2013;8. https://doi.org/10.3109/17482968.2010.543688 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.543688</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, Stommel EW, Shi X, et al. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology. 2015;85:1822&#x2013;3. https://doi.org/10.1212/01.wnl.0000473800.89178.a9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000473800.89178.a9</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox E (1989) Detection of clusters. In: Methodology of enquiries into disease clustering. London: small area health statistics unit Elliot P: 17&#x2013;20</Citation></Reference><Reference><Citation>Elliott P, Wartenberg D. Spatial epidemiology: current approaches and future challenges. Environ Health Perspect. 2004;112:998&#x2013;1006. https://doi.org/10.1289/ehp.6735 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.6735</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MHB, de Jong SW, van Doormaal PTC, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165&#x2013;70. https://doi.org/10.1136/jnnp.2011.244939 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2011.244939</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, El Abdellaoui S, Sarazin C, et al. Validation of the analytical procedure for the determination of the neurotoxin &#x3b2;-N-methylamino-L-alanine in complex environmental samples. Anal Chim Acta. 2013;771:42&#x2013;9. https://doi.org/10.1016/j.aca.2013.02.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2013.02.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, El Abdellaoui S, Vial J, et al. Development of an analytical procedure for quantifying the underivatized neurotoxin &#x3b2;-N-methylamino-L-alanine in brain tissues. Anal Bioanal Chem. 2014;406:4627&#x2013;36. https://doi.org/10.1007/s00216-014-7872-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-014-7872-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda P, Combes A, Petit J, et al. Synthesis of a molecularly imprinted sorbent for selective solid-phase extraction of &#x3b2;-N-methylamino-L-alanine. Talanta. 2015;144:1021&#x2013;9. https://doi.org/10.1016/j.talanta.2015.07.052 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.talanta.2015.07.052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>